Read more: Manuel A. Navia, Ph.D. Axel Unterbeck, Ph.D. B. Christopher Kim, Ph.D. David Armistead, Ph.D.
Investment Type: Venture Capital
Mentions in press and media 10
| Date | Title | Description | Source |
| 02.04.2012 | Former head of Sanofi vaccines division becomes infectious d... | Last year, it was granted a five-year research grant valued up to $196 million by the Biomedical Adv... | medcitynew... |
| 30.03.2009 | Pathway Medical lands generous $40M to treat arterial diseas... | Pathway Medical Technologies, maker of a non-invasive catheter capable of removing all kinds of arte... | venturebea... |
| 20.03.2009 | Surprised? Oxford Bioscience Partners Lands, Briefly, on Dre... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints It’s always slightly shocking to f... | xconomy.co... |
| 02.02.2009 | New England VCs Well Down Midas List—Oxford’s Fambrough Lead... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Mike Moritz, John Doerr. John Doer... | xconomy.co... |
| 08.01.2009 | Concentric Medical closes $15M to ease stroke symptoms | Concentric Medical, developer of minimally invasive devices used to remove blood clots in ischemic s... | venturebea... |
| 14.10.2008 | Migraine sufferers look elsewhere as Cierra buckles | The headache is over for medical device maker Cierra. Actually it’s all over. The Redwood City, Cali... | venturebea... |
| 07.06.2007 | Amgen snaps up another biotech startup, Alantos Pharma, for ... | Amgen suddenly has a voracious appetite for startups. In its second deal this week, the biotech gian... | venturebea... |
| 04.05.2007 | Cancer-drug maker Aveo raises $53M | Aveo Pharmaceuticals, a Cambridge, Mass. cancer-drug company, raised $53 million in a fourth round o... | venturebea... |
| 29.09.2004 | Amadeus leads $14.4 million Series B financing in Solexa | Amadeus leads $14.4 million Series B financing in Solexa 29-09-2004 Amadeus Capital Partners has l... | cambridgen... |
| - | Former head of Sanofi vaccines division becomes infectious d... | The former head of Sanofi’s (NYSE:SNY) vaccines division, one of the largest vaccine companies in th... | medcitynew... |